Pharma

Advanced instrument vendors are now prioritizing data integrity and regulatory compliance to meet the rigorous demands of Good Manufacturing Practice environments. This shift reflects a broader transformation where analytical science has moved beyond its traditional role as a secondary support

Initial development for GEA's predictive intelligence tools is focused on continuous processing lines with future plans to expand to batch equipment. This strategic focus highlights a broader industry shift as pharmaceutical manufacturers move away from isolated, manual operations toward fully

Analytical chemists have moved beyond traditional spectrophotometric techniques because these older methods cannot achieve the parts-per-billion sensitivity required to detect modern nitrosamine contaminants. The initial discovery of N-nitrosodimethylamine (NDMA) in the "Sartan" class of blood

Computational modeling now allows scientists to predict the most effective crystal forms of a compound before significant material is synthesized, streamlining the early stages of pharmaceutical development. This capability represents a monumental shift in a field where the transition from a

The global pharmaceutical landscape is currently navigating a period where the ability to manufacture highly specialized therapies rapidly has become more critical than the sheer volume of production itself, forcing a total reimagining of traditional outsourcing relationships. This roundup examines

A coordinated effort to hide documents in lockers and pour out evidence suggests a culture of deception at certain Chinese manufacturing plants supplying the U.S. This alarming discovery comes at a time when the demand for GLP-1 receptor agonists, such as semaglutide and tirzepatide, has reached